What Animal Models Tell Us About Treatments for Pulmonary Hypertension (English)
- New search for: Wilkins, M.R.
- New search for: Wharton, J.
- New search for: Zhao, L.
- New search for: Solvay Pharmaceuticals
- New search for: Wilkins, M.R.
- New search for: Wharton, J.
- New search for: Zhao, L.
- New search for: Antel, J.
- New search for: Hesselink, M. B.
- New search for: Schermuly, R. T.
- New search for: Solvay Pharmaceuticals
In:
Solvay pharmaceuticals conference; Pulmonary arterial hypertension: focusing on a future: enhancing and extending life
;
57-70
;
2010
-
ISBN:
-
ISSN:
- Conference paper / Print
-
Title:What Animal Models Tell Us About Treatments for Pulmonary Hypertension
-
Contributors:Wilkins, M.R. ( author ) / Wharton, J. ( author ) / Zhao, L. ( author ) / Antel, J. / Hesselink, M. B. / Schermuly, R. T. / Solvay Pharmaceuticals
-
Conference:10th, Solvay pharmaceuticals conference; Pulmonary arterial hypertension: focusing on a future: enhancing and extending life ; 2008 ; Riga
-
Published in:SOLVAY PHARMACEUTICALS CONFERENCES ; 10 ; 57-70
-
Publisher:
- New search for: IOS Press
-
Place of publication:Amsterdam
-
Publication date:2010-01-01
-
Size:14 pages
-
Remarks:Includes bibliographical references and index.
-
ISBN:
-
ISSN:
-
Type of media:Conference paper
-
Type of material:Print
-
Language:English
-
Keywords:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents conference proceedings
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 5
-
Surgical Treatment of Pulmonary Arterial HypertensionDartevelle, P.G. / Solvay Pharmaceuticals et al. | 2010
- 13
-
Pulmonary Arterial Hypertension Associated with Systemic Sclerosis: A Need for a More Focused ApproachHassoun, P.M. / Solvay Pharmaceuticals et al. | 2010
- 25
-
Established and New Therapies for Hypoxia and Non-Hypoxia-Related Pulmonary HypertensionGhofrani, H.A. / Voswinckel, R. / Reichenberger, F. / Weissmann, N. / Schermuly, R.T. / Seeger, W. / Grimminger, F. / Solvay Pharmaceuticals et al. | 2010
- 41
-
Novel Anti-Proliferative Therapies in Pulmonary HypertensionJanssen, W. / Schermuly, R.T. / Solvay Pharmaceuticals et al. | 2010
- 57
-
What Animal Models Tell Us About Treatments for Pulmonary HypertensionWilkins, M.R. / Wharton, J. / Zhao, L. / Solvay Pharmaceuticals et al. | 2010
- 71
-
Therapeutic Potential for Dual Inhibition of Endothelin Converting Enzyme and Neutral Endopeptidase in Pulmonary Arterial HypertensionFischer, Y. / Solvay Pharmaceuticals et al. | 2010
- 85
-
Pulmonary Vascular Disease in the Newborn - From Pathophysiology to Therapeutic StrategiesSluiter, I. / Kraemer, U. / Rottier, R. / Tibboel, D. / Reiss, I. / Solvay Pharmaceuticals et al. | 2010
- 93
-
From Concept to Therapy - Alternative Route of Drug Application: InhalationOlschewski, H. / Solvay Pharmaceuticals et al. | 2010